Nexalin Technology prices registered direct offering of 2,419,355 shares at $0.31 each

Nexalin Technology entered a securities purchase agreement for a registered direct offering of 2,419,355 common shares at $0.31 each.

Gross proceeds are expected to be about $750,000 before expenses, and closing is expected on or about Aug. 20, 2026.

The concurrent private placement includes common stock warrants for 1,209,677 shares at a $0.50 exercise price, expiring in one year.

If fully exercised for cash, the warrants would add about $604,839. The warrants may be exercised on a cashless basis if no effective resale registration is available.

Maxim Group is to receive a $100,000 advisory fee at closing. It is not acting as underwriter or placement agent.